Cargando…
Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
BACKGROUND: Epithelial ovarian cancer (EOC) has the lowest survival rate among female reproductive cancers present with symptoms of aggressive malignancies, poor prognosis, drug resistance and postoperative recurrence. The majority of patients with EOC are diagnosed at an advanced stage due to the t...
Autores principales: | Wang, Kai, Guan, Chenan, Yu, Junhui, Chen, Xing, Shang, Xianwen, Mei, Shuangshuang, Feng, Xingjun, Zheng, Lingzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646314/ https://www.ncbi.nlm.nih.gov/pubmed/36393971 http://dx.doi.org/10.1155/2022/9328972 |
Ejemplares similares
-
Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2017) -
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer
por: Wang, Kai, et al.
Publicado: (2021) -
Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
por: Zhang, Zheng, et al.
Publicado: (2021) -
Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer
por: Chen, Buze, et al.
Publicado: (2023) -
Prognostic and Immunological Roles of MMP-9 in Pan-Cancer
por: Zeng, Yudan, et al.
Publicado: (2022)